First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence.

por Sandercock, J., Parmar, M. K., Torri, V.
Publicado 1998

First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence

por Sandercock, J, Parmar, M K B, Torri, V, Qian, W
Publicado 2002

No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials

por Abdel-Rahman, M E, Butler, J, Sydes, M R, Parmar, M K B, Gordon, E, Harper, P, Williams, C, Crook, A, Sandercock, J, Swart, A M, Rachet, B, Coleman, M P
Publicado 2014